Kamada (KMDA) Asset Writedowns and Impairment (2016 - 2017)
Kamada (KMDA) reported Asset Writedowns and Impairment of -$3000.0 for Q4 2017, down 160.0% on a YoY basis from $5000.0 in Q4 2016, and down 160.0% quarter-over-quarter from $5000.0 in Q4 2016.
Kamada (KMDA) Asset Writedowns and Impairment (2016 - 2017) Analysis & Trends
Kamada has reported Asset Writedowns and Impairment for 2 years, with the latest figure at -$3000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -3,000.00 |
| Dec 31, 2017 | -3,000.00 |
| Dec 31, 2016 | 5,000.00 |
| Dec 31, 2016 | 5,000.00 |
| Mar 31, 2016 | 10,000.00 |
| Mar 31, 2016 | 10,000.00 |